Latest Breaking News On - Director bvf partners - Page 1 : comparemela.com

Kymera Therapeutics (NASDAQ:KYMR) Stock Price Up 5 7%

Kymera Therapeutics (NASDAQ:KYMR) Stock Price Up 5 7%
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United statesHong kongLeerink partnrsEllen chiniaraMorgan stanleySecurities exchange commissionHong kong ltdWells fargo companyAdvisors asset management incTower research capitalRoyal bankKymera therapeutics company profileJpmorgan chase coKymera therapeutics incKymera therapeuticsGet free report

AtonRa Partners Sells 2,775 Shares of Kymera Therapeutics, Inc (NASDAQ:KYMR)

AtonRa Partners Sells 2,775 Shares of Kymera Therapeutics, Inc (NASDAQ:KYMR)
etfdailynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from etfdailynews.com Daily Mail and Mail on Sunday newspapers.

United statesLeerink partnrsPiper sandlerCongress asset management coRaymond james associatesJpmorgan chase coSecurities exchange commissionAmerican international group incKymera therapeutics company profileKymera therapeutics incRoyal bankMorgan stanleyGroup plcAtonra partnersKymera therapeuticsFree report

Kymera Therapeutics (NASDAQ:KYMR) Shares Gap Up to $27 22

Kymera Therapeutics, Inc. (NASDAQ:KYMR – Get Free Report) gapped up prior to trading on Friday . The stock had previously closed at $27.22, but opened at $29.93. Kymera Therapeutics shares last traded at $27.30, with a volume of 654,432 shares trading hands. Wall Street Analyst Weigh In A number of equities analysts have recently commented […]

United statesAmerican international group incRaymond james associatesJpmorgan chase coGroup plcCongress asset management coRoyal bankWells fargo companyMorgan stanleyKymera therapeutics incKymera therapeuticsGet free reportDirector bvf partnersGeneral group plcAsset managementInternational group

Kymera Therapeutics (NASDAQ:KYMR) Trading Up 8 2%

Kymera Therapeutics, Inc. (NASDAQ:KYMR – Get Free Report) shares traded up 8.2% on Wednesday . The company traded as high as $27.04 and last traded at $27.00. 288,646 shares were traded during trading, a decline of 49% from the average session volume of 571,203 shares. The stock had previously closed at $24.96. Analysts Set New […]

Leerink partnrsPiper sandlerKymera therapeutics incDimensional fund advisorsYork mellon corpWells fargo companyMorgan stanleyMetlife investment managementBlackrock incKymera therapeuticsGet free reportDirector bvf partnersNew york mellon corpLife investment managementFund advisorsKymera therapeutics daily

Kymera Therapeutics, Inc (NASDAQ:KYMR) Given Average Recommendation of Moderate Buy by Analysts

Shares of Kymera Therapeutics, Inc. (NASDAQ:KYMR – Get Free Report) have been given a consensus rating of “Moderate Buy” by the eleven ratings firms that are currently covering the stock, Marketbeat Ratings reports. Four analysts have rated the stock with a hold rating and seven have given a buy rating to the company. The average […]

Hong kongLeerink partnrsPiper sandlerHong kong ltdCredit suisse groupKymera therapeutics company profileRoyal bankMorgan stanleySecurities exchange commissionAdvisors asset management incTower research capitalKymera therapeutics incKymera therapeuticsGet free reportMarketbeat ratingsSuisse group